Study on Free Light Chain Removal in Multiple Myeloma Patients
Author Information
Author(s): Colin A Hutchison, Mark Cook, Nils Heyne, Katja Weisel, Lucinda Billingham, Arthur Bradwell, Paul Cockwell
Primary Institution: University Hospital Birmingham, Birmingham, UK
Hypothesis
FLC removal haemodialysis will increase the rate of renal recovery in patients with severe renal failure secondary to cast nephropathy in de novo multiple myeloma.
Conclusion
The study aims to evaluate the effectiveness of FLC removal haemodialysis in improving renal recovery in patients with cast nephropathy and multiple myeloma.
Supporting Evidence
- FLC removal by extended haemodialysis has been shown to improve clinical outcomes in early pilot studies.
- In a previous study, 12 out of 17 patients treated with FLC removal recovered sufficient renal function to become independent of dialysis.
Takeaway
This study is trying to find out if a special type of dialysis can help people with kidney problems caused by a type of blood cancer get better faster.
Methodology
A prospective, randomised, multicentre, open label clinical trial comparing FLC removal haemodialysis with standard high flux haemodialysis.
Participant Demographics
Patients with cast nephropathy, dialysis dependent acute renal failure, and de novo multiple myeloma, aged over 18.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website